Natural product-derived therapy for Allergic rhinitis: Eriocitrin, found in Lemons, inhibits GM-CSF, Interleukin 13 receptor(IL-13)-Rα1, and eotaxin expression, among others, inhibits mucus production and alleviates allergic rhinitis via up regulation of its target gene, 2/April/2017, 5.38 am

Molecular therapy for enhancing the efficacy of tyrosine-kinase inhibitor (TKI) therapy in BCR-ABL-induced Human leukemia: Methyl Jasmonate (MJ), one of the main component of Jasmine, decreases the expression of oncoproteins c-FOS, DUSP1 and BCR-ABL, inhibits TKI resistance, restores treatment responsiveness, increases therapeutic index of anticancer drugs, and cure CML and kinase-driven cancers via up-regulation of its target gene, 2/April/2017, 5.24 am
April 1, 2017
Molecular therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Chitooligosaccharides, one of the degradative products of Chitosan, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of its target gene, 2/April/2017, 7.49 am
April 2, 2017
Show all

What we say:

Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived therapy for Allergic rhinitis: Eriocitrin, found in Lemons,  inhibits GM-CSF, Interleukin 13 receptor(IL-13)-Rα1, and eotaxin expression, among others, inhibits mucus production and alleviates allergic rhinitis via up regulation of its target gene


From Significance of the study to Public health relevance:

Given that: (1) in any given year, nearly 20-30% of people are affected by Allergic Rhinitis; (2) most of the medications available today for allergic rhinitis treats only the symptoms, and provide temporary relief; (3) corticosteroid therapy for allergic rhinitis may have its own side effects; (4) the global economic cost spent in the treatment of allergic rhinitis is enormous, there is an urgent need to find: (i) a way to cure allergic rhinitis, without adverse side effects; (ii) a cheaper alternative to the existing expensive medications; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, allergic rhinitis.


From Research findings to Therapeutic opportunity:

This study suggests, for the first time, a natural product based therapy for Allergic Rhinitis. Eriocitrin, by increasing the expression of its target genes, it may: (1) inhibit GM-CSF levels; (2) decrease IL13Rα1 expression; (3) suppress eotaxin expression; and (4) inhibit mucus production (figs. 1-2).

Eriocitrin க்கான பட முடிவு

Figure 1. The chemical structure of Eriocitrin

lemons க்கான பட முடிவு

Figure 2. Lemon fruits. Eriocitrin, found in Lemons, inhibits the development and progression of Allergic Rhinitis

Thus, pharmacological formulations encompassing Eriocitrin or its analogues either alone or in combination with other drugs” may be used to control allergic rhinitis.


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does Eriocitrin decrease the expression of GM-CSF/L13Ra1/eotaxin to inhibit allergic rhinitis?

Amount: $50

# Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org


References:

Web: http://genomediscovery.org or http://newbioideas.com

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, L., Natural product-derived therapy for Allergic rhinitis: Eriocitrin, found in Lemons,  inhibits GM-CSF, Interleukin 13 receptor(IL-13)-Rα1, and eotaxin expression, among others, inhibits mucus production and alleviates allergic rhinitis via up regulation of its target gene, 2/April/2017, 5.38 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.